SCHEMBL4931806

SCHEMBL4931806

Cc1cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)cc(NC2CCC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.39
TAOK1 Q7L7X3 1/20 0.38
TAOK3 Q9H2K8 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
GAA P10253 2/20 0.34
USP5 P45974 2/20 0.34
RAB9A P51151 2/20 0.34
SLC6A5 Q9Y345 2/20 0.34
HDAC6 Q9UBN7 1/20 0.34
NPC1 O15118 1/20 0.34
ABL1 P00519 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717962 0.95 F2 (0.37) F2TAOK1TAOK3PDE4APDE4B
SCHEMBL4360211 0.90 MEN1 (0.39) F2TAOK1TAOK3PDE4APDE4B
SCHEMBL4926882 0.90 PDE4A (0.36) F2TAOK1TAOK3PDE4APDE4B
SCHEMBL4931877 0.88 PDE4A (0.35) TAOK1TAOK3PDE4APDE4BPDE4C
SCHEMBL5717965 0.87 F2 (0.36) F2TAOK1TAOK3HSD17B10MEN1
SCHEMBL4932680 0.86 MRGPRX4 (0.42) TAOK1TAOK3MEN1KMT2AALDH1A1
SCHEMBL4933162 0.86 MRGPRX4 (0.42) USP5
SCHEMBL4929677 0.86 MRGPRX4 (0.38) TAOK1TAOK3PDE4APDE4BPDE4C
SCHEMBL5718186 0.86 PTGDR (0.34) TAOK1TAOK3PDE4APDE4BPDE4C
SCHEMBL4934576 0.85 KMT2A (0.40) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA F2 2898/4885TAOK1 1381/4885TAOK3 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.